BackAstria Therapeutics Overview

Astria Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ATXS.

Quarterly EBIT

-$34.10M
↓ 17.54% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$136.47M
↓ 35.18% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin